SEC Form 4 research
| Issuer | Tarsus Pharmaceuticals, Inc. |
|---|---|
| Tickers | TARS |
| Reporting owners | 30 |
| Officers and directors | 13 |
| Last public filing | 2026-09-17 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-17 | 2026-09-15 | LINK WILLIAM J PHD | S | 66 | $80.01 | Not reported |
| 2026-09-17 | 2026-09-15 | LINK WILLIAM J PHD | S | 759 | $79 | Not reported |
| 2026-09-17 | 2026-09-15 | LINK WILLIAM J PHD | S | 11,675 | $78.33 | Not reported |
| 2026-09-09 | 2026-09-04 | Azamian Bobak R. | S | 2,900 | $91.27 | Not reported |
| 2026-09-09 | 2026-09-04 | Azamian Bobak R. | S | 7,100 | $90.27 | Not reported |
| 2026-09-09 | 2026-09-04 | Lin Elizabeth Yeu | S | 1,590 | $90 | Not reported |
| 2026-09-09 | 2026-09-04 | Lin Elizabeth Yeu | S | 1,590 | $85 | Not reported |
| 2026-09-09 | 2026-09-04 | Lin Elizabeth Yeu | S | 5,386 | $90 | Not reported |
| 2026-09-09 | 2026-09-04 | Lin Elizabeth Yeu | S | 5,387 | $85 | Not reported |
| 2026-09-09 | 2026-09-04 | Neervannan Seshadri | S | 4,564 | $85 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.